Plan campaigns, create assets for healthcare professionals and for consumers, and clear every claim against your SmPC and local promotional rules before the review round opens. Rx and OTC, one workflow, one audit trail.
HCP_Approved_Email_Q3.pdf
Cardiology · DE market · v3
In review
MLRMandatory information incomplete, dosage form missing
ClaimNot covered by the approved SmPC, section 5.1
12 further checks passed, sources verified
Trusted by Leading Companies
The problem
Approval is the expensive part of every campaign.
Promotional material has to satisfy Marketing, Medical, Legal and Regulatory at once. That makes review complex. Complex reviews are slow reviews, and slow reviews are expensive ones.
Today
With Caidera
3 to 6months
From the first idea to the approved asset. Every round adds weeks, and the moment the campaign was built for has passed.
Checked in minutes
Caidera checks the draft against the promotional rules and your approved SmPC before it reaches a single reviewer.
1,700hours
Per person per year spent reviewing promotional material by hand, line by line, asset by asset.
Up to 80% less manual review
People still decide, but only on the judgement calls. The obvious findings are resolved before the round opens.
$35 bnin fines
Paid by pharmaceutical companies in settlements over unlawful promotion of their products.
Every claim checked, systematically
Measured against the approved label and the promotional rules of each market, with the source on file.
Workflow
One workflow, from briefing to performance.
The same brand knowledge base, reference library and audit trail at every stage, so nothing is re-explained and nothing gets lost between tools.
Where marketing, medical, legal and regulatory work together
Campaign plan, drafting, review, brand rules and assets, every one of them working off the same knowledge base and reference library, configured for your products and markets.
Campaign planQ3
HCPConsumerDEAT
Campaign planning
Brief, audience and channels per specialist group and market
Approved Email
Newsletter
Banner
Content creation
Approved emails, newsletters and banners out of one brief
DraftMedicalLegalApproval
MLR · Mandatory information
Compliance check
MLR requirements, SmPC and your brand rules in a single run, with sources
Brand rules
active
Mandatory text
Brand hub
Brand rules, mandatory texts and tone of voice in one place instead of a PDF nobody opens
Assetsapproved
v4
v2
v7
Asset library
Approved assets, versioned and findable, with the review that cleared them attached
Compliance
What Caidera checks in pharma assets
The bottleneck is rarely the MLR team. It's the unclear guidance that reaches them. So the rule base for Marketing, Medical, Legal and Regulatory sits in one place, and checks run against your own reference library, the approved SmPC and the promotional rules of each market.
Mandatory information and mandatory text, including the adverse-effect notice
Prescription-only products never promoted to consumers
Testimonials, celebrities and influencers in consumer advertising
Misleading or unsupported efficacy claims
Claims measured against the approved SmPC
Indication and dosage within the marketing authorisation
Comparative advertising backed by the SmPC of both products
Industry code requirements for HCP communication
Source references present, cited correctly and current
Rule sets are configured per market and per product, for Rx and OTC alike. Your own brand and MLR requirements sit alongside them. The EU Pharma Package will tighten the advertising rules over the coming years, comparative and consumer advertising among them. Rule sets follow once the text is final.
Case Study
What that looks like in practice
Leading International Pharma Company
With Caidera, we produce regulation-compliant HCP assets in a fraction of the time and cost. The platform understands our compliance requirements and delivers approval-ready results.
